|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.718
|
|
|
complement activation
|
GO:0006956 |
16 |
0.698
|
Human |
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.585
|
|
|
protein activation cascade
|
GO:0072376 |
19 |
0.479
|
Human |
|
angiogenesis
|
GO:0001525 |
201 |
0.460
|
Mouse |
|
protein processing
|
GO:0016485 |
163 |
0.456
|
|
|
positive regulation of activation of membrane attack complex
|
GO:0001970 |
2 |
0.418
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.401
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.386
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.385
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.354
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.338
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.319
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.283
|
Human |
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.278
|
|
|
establishment of blood nerve barrier
|
GO:0008065 |
3 |
0.274
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.274
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.268
|
Human |
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.264
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.263
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.257
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.245
|
|
|
humoral immune response
|
GO:0006959 |
57 |
0.244
|
Human |
|
mapk cascade
|
GO:0000165 |
281 |
0.244
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.234
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.227
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.219
|
Mouse |
|
ossification
|
GO:0001503 |
216 |
0.215
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.215
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.214
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.213
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.207
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.200
|
|
|
kidney development
|
GO:0001822 |
213 |
0.199
|
|
|
regulation of blood pressure
|
GO:0008217 |
93 |
0.198
|
Mouse |
|
regulation of cell motility
|
GO:2000145 |
236 |
0.192
|
|
|
negative regulation of tooth mineralization
|
GO:0070171 |
1 |
0.190
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.188
|
Mouse |
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.183
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.180
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.178
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.177
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.177
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.166
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.164
|
Mouse |
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.163
|
|
|
endothelium development
|
GO:0003158 |
45 |
0.160
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.159
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.157
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.156
|
Mouse |
|
positive regulation of protein kinase b signaling
|
GO:0051897 |
32 |
0.154
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.154
|
Human |
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.150
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.149
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.144
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.143
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.142
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.141
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.141
|
Mouse |
|
regulation of glucose metabolic process
|
GO:0010906 |
60 |
0.140
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.139
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.132
|
Mouse |
|
chondroitin sulfate proteoglycan metabolic process
|
GO:0050654 |
20 |
0.129
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.127
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.126
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.125
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.125
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.124
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.121
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.119
|
|
|
response to interferon gamma
|
GO:0034341 |
34 |
0.118
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.117
|
Mouse |
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.117
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.116
|
|
|
regulation of tooth mineralization
|
GO:0070170 |
2 |
0.114
|
|
|
positive regulation of protein kinase c activity
|
GO:1900020 |
1 |
0.113
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.112
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.112
|
|
|
peptidyl serine modification
|
GO:0018209 |
83 |
0.110
|
|
|
astrocyte activation
|
GO:0048143 |
2 |
0.109
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.108
|
|
|
positive regulation of fatty acid biosynthetic process
|
GO:0045723 |
3 |
0.108
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.106
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.106
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.103
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.100
|
|
|
ovarian follicle rupture
|
GO:0001543 |
2 |
0.100
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.098
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.098
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.098
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.097
|
Human |
|
regulation of protein processing
|
GO:0070613 |
96 |
0.097
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.096
|
|
|
peptide cross linking
|
GO:0018149 |
10 |
0.094
|
|
|
negative regulation of odontogenesis
|
GO:0042483 |
3 |
0.094
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.094
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.093
|
Mouse |
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.093
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.091
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.091
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.089
|
|
|
gluconeogenesis
|
GO:0006094 |
39 |
0.089
|
|
|
regulation of fatty acid metabolic process
|
GO:0019217 |
28 |
0.088
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.088
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.086
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.086
|
|
|
production of molecular mediator of immune response
|
GO:0002440 |
103 |
0.085
|
|
|
lung development
|
GO:0030324 |
164 |
0.085
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.085
|
|
|
endocrine process
|
GO:0050886 |
39 |
0.083
|
Mouse |
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.082
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.082
|
Mouse |
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.082
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.081
|
Mouse |
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.080
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.080
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.079
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.079
|
Mouse |
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.079
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.078
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.078
|
Human |
|
gland development
|
GO:0048732 |
330 |
0.078
|
Mouse |
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.076
|
|
|
negative regulation of cellular carbohydrate metabolic process
|
GO:0010677 |
19 |
0.073
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.072
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.072
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.072
|
|
|
sulfur compound metabolic process
|
GO:0006790 |
100 |
0.072
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.070
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.070
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.070
|
|
|
positive regulation of neutrophil migration
|
GO:1902624 |
12 |
0.070
|
|
|
terpenoid metabolic process
|
GO:0006721 |
25 |
0.069
|
|
|
female sex differentiation
|
GO:0046660 |
84 |
0.069
|
|
|
positive regulation of inflammatory response
|
GO:0050729 |
47 |
0.069
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.068
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.067
|
|
|
chondroitin sulfate metabolic process
|
GO:0030204 |
17 |
0.066
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.066
|
Mouse |
|
mucopolysaccharide metabolic process
|
GO:1903510 |
25 |
0.066
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.065
|
|
|
regulation of cellular carbohydrate metabolic process
|
GO:0010675 |
75 |
0.065
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.065
|
|
|
positive regulation of peptidyl serine phosphorylation
|
GO:0033138 |
25 |
0.064
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.064
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.063
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.063
|
|
|
renal system development
|
GO:0072001 |
225 |
0.063
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.062
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.062
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.062
|
|
|
entry into cell of other organism involved in symbiotic interaction
|
GO:0051806 |
15 |
0.062
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.061
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.061
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.059
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.059
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.058
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.058
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.057
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.057
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.056
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.056
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.056
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.056
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.055
|
|
|
cellular response to peptide hormone stimulus
|
GO:0071375 |
92 |
0.055
|
|
|
endothelial cell development
|
GO:0001885 |
20 |
0.054
|
|
|
long chain fatty acid import
|
GO:0044539 |
2 |
0.054
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.054
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.053
|
Mouse |
|
nephron development
|
GO:0072006 |
109 |
0.053
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.052
|
|
|
skin development
|
GO:0043588 |
220 |
0.052
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.052
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.052
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.052
|
|
|
wound healing
|
GO:0042060 |
157 |
0.051
|
|
|
negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090101 |
61 |
0.050
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.050
|
|
|
hexose transport
|
GO:0008645 |
56 |
0.049
|
|
|
proteoglycan metabolic process
|
GO:0006029 |
38 |
0.049
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.049
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.049
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.048
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.047
|
|
|
protein kinase b signaling
|
GO:0043491 |
74 |
0.047
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.047
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.047
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.047
|
|
|
kidney epithelium development
|
GO:0072073 |
121 |
0.046
|
|
|
response to corticosteroid
|
GO:0031960 |
20 |
0.046
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.045
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.045
|
|
|
regulation of gluconeogenesis
|
GO:0006111 |
30 |
0.045
|
|
|
response to monosaccharide
|
GO:0034284 |
67 |
0.044
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.044
|
Mouse |
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.044
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.044
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.043
|
|
|
glycosaminoglycan metabolic process
|
GO:0030203 |
34 |
0.043
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.043
|
Human |
|
cell chemotaxis
|
GO:0060326 |
81 |
0.043
|
|
|
diterpenoid metabolic process
|
GO:0016101 |
24 |
0.043
|
|
|
cell cell adhesion
|
GO:0098609 |
41 |
0.042
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.042
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.042
|
|
|
positive regulation of glucose transport
|
GO:0010828 |
16 |
0.042
|
|
|
regulation of cellular response to insulin stimulus
|
GO:1900076 |
30 |
0.041
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.041
|
|
|
gliogenesis
|
GO:0042063 |
141 |
0.041
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.040
|
|
|
activation of nf kappab inducing kinase activity
|
GO:0007250 |
4 |
0.040
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.040
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.040
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.040
|
|
|
angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure
|
GO:0001998 |
3 |
0.040
|
|
|
peptide cross linking via chondroitin 4 sulfate glycosaminoglycan
|
GO:0019800 |
8 |
0.039
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.039
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.038
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.038
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.038
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.038
|
|
|
female gonad development
|
GO:0008585 |
71 |
0.037
|
|
|
positive regulation of protein activation cascade
|
GO:2000259 |
2 |
0.037
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.036
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.036
|
|
|
entry into other organism involved in symbiotic interaction
|
GO:0051828 |
15 |
0.036
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.036
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.035
|
Mouse |
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.035
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.035
|
|
|
hormone metabolic process
|
GO:0042445 |
86 |
0.035
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.035
|
|
|
transforming growth factor beta receptor signaling pathway
|
GO:0007179 |
71 |
0.035
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.035
|
|
|
glucocorticoid metabolic process
|
GO:0008211 |
9 |
0.034
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.034
|
|
|
regulation of complement activation
|
GO:0030449 |
7 |
0.034
|
Human |
|
monosaccharide biosynthetic process
|
GO:0046364 |
44 |
0.034
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.034
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.034
|
|
|
neuron death
|
GO:0070997 |
154 |
0.034
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.033
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.033
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.033
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.033
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.033
|
|
|
response to transforming growth factor beta
|
GO:0071559 |
88 |
0.033
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.033
|
|
|
ovulation cycle
|
GO:0042698 |
59 |
0.033
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.032
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.032
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.032
|
Human |
|
astrocyte differentiation
|
GO:0048708 |
43 |
0.032
|
|
|
negative regulation of transforming growth factor beta receptor signaling pathway
|
GO:0030512 |
26 |
0.032
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.032
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.031
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.031
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.031
|
Mouse |
|
renal system process
|
GO:0003014 |
48 |
0.030
|
Mouse |
|
nephron epithelium development
|
GO:0072009 |
92 |
0.030
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.030
|
|
|
entry into host
|
GO:0044409 |
15 |
0.030
|
|
|
monosaccharide transport
|
GO:0015749 |
58 |
0.029
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.029
|
|
|
negative regulation of platelet derived growth factor receptor alpha signaling pathway
|
GO:2000584 |
2 |
0.029
|
|
|
regulation of protein kinase b signaling
|
GO:0051896 |
56 |
0.029
|
|
|
glucose transport
|
GO:0015758 |
56 |
0.028
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.028
|
|
|
isoprenoid metabolic process
|
GO:0006720 |
29 |
0.028
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.028
|
|
|
negative regulation of carbohydrate metabolic process
|
GO:0045912 |
19 |
0.028
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.028
|
|
|
regulation of cholesterol metabolic process
|
GO:0090181 |
14 |
0.028
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.028
|
|
|
regulation of transforming growth factor beta receptor signaling pathway
|
GO:0017015 |
43 |
0.028
|
|
|
positive regulation of apoptotic cell clearance
|
GO:2000427 |
3 |
0.027
|
|
|
tooth mineralization
|
GO:0034505 |
9 |
0.027
|
|
|
cellular response to steroid hormone stimulus
|
GO:0071383 |
33 |
0.027
|
|
|
negative regulation of blood vessel morphogenesis
|
GO:2000181 |
25 |
0.027
|
Mouse |
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.027
|
Human |
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.027
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
43 |
0.027
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.027
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.026
|
Mouse |
|
leukocyte tethering or rolling
|
GO:0050901 |
3 |
0.026
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
0.026
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.026
|
Mouse |
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.026
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.026
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.026
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.026
|
|
|
cell growth
|
GO:0016049 |
130 |
0.025
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.025
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.025
|
|
|
retinoid metabolic process
|
GO:0001523 |
24 |
0.025
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.025
|
|
|
neutrophil migration
|
GO:1990266 |
37 |
0.025
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.025
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.025
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.025
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.024
|
|
|
regulation of renal output by angiotensin
|
GO:0002019 |
2 |
0.024
|
|
|
negative regulation of gluconeogenesis
|
GO:0045721 |
9 |
0.024
|
|
|
regulation of glucose transport
|
GO:0010827 |
32 |
0.024
|
|
|
metanephric glomerular visceral epithelial cell development
|
GO:0072249 |
2 |
0.024
|
|
|
adiponectin secretion
|
GO:0070162 |
2 |
0.024
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.024
|
|
|
entry into host cell
|
GO:0030260 |
15 |
0.024
|
|
|
positive regulation of reactive oxygen species biosynthetic process
|
GO:1903428 |
2 |
0.024
|
|
|
defense response to gram positive bacterium
|
GO:0050830 |
50 |
0.024
|
|
|
regulation of platelet derived growth factor receptor alpha signaling pathway
|
GO:2000583 |
2 |
0.024
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.024
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.024
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.023
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.023
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.023
|
|
|
carbohydrate transport
|
GO:0008643 |
62 |
0.023
|
|
|
negative regulation of cellular response to growth factor stimulus
|
GO:0090288 |
46 |
0.023
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.023
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.023
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.023
|
|
|
negative regulation of intrinsic apoptotic signaling pathway
|
GO:2001243 |
34 |
0.023
|
|
|
regulation of reactive oxygen species biosynthetic process
|
GO:1903426 |
2 |
0.023
|
|
|
regulation of lymphocyte mediated immunity
|
GO:0002706 |
84 |
0.022
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.022
|
Mouse |
|
regulation of cell size
|
GO:0008361 |
72 |
0.022
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.022
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.022
|
|
|
regulation of protein activation cascade
|
GO:2000257 |
7 |
0.022
|
Human |
|
aminoglycan metabolic process
|
GO:0006022 |
34 |
0.022
|
|
|
regulation of systemic arterial blood pressure by hormone
|
GO:0001990 |
25 |
0.022
|
Mouse |
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.022
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.022
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.021
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.021
|
|
|
immunoglobulin mediated immune response
|
GO:0016064 |
69 |
0.021
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.021
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.021
|
|
|
cellular response to monosaccharide stimulus
|
GO:0071326 |
47 |
0.021
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.021
|
|
|
regulation of acute inflammatory response
|
GO:0002673 |
27 |
0.021
|
Human |
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.021
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.020
|
|
|
interleukin 27 mediated signaling pathway
|
GO:0070106 |
1 |
0.020
|
|
|
phosphatidylinositol 3 kinase signaling
|
GO:0014065 |
36 |
0.020
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.020
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
74 |
0.020
|
|
|
regulation of neutrophil chemotaxis
|
GO:0090022 |
14 |
0.020
|
|
|
metanephric glomerular epithelium development
|
GO:0072244 |
3 |
0.019
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.019
|
|
|
cerebellum development
|
GO:0021549 |
77 |
0.019
|
|
|
movement in host environment
|
GO:0052126 |
15 |
0.019
|
|
|
cellular response to glucocorticoid stimulus
|
GO:0071385 |
13 |
0.019
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.019
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.019
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.019
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.019
|
|
|
nephron morphogenesis
|
GO:0072028 |
69 |
0.018
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.018
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.018
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.018
|
|
|
lipid catabolic process
|
GO:0016042 |
69 |
0.018
|
|
|
fat soluble vitamin biosynthetic process
|
GO:0042362 |
4 |
0.018
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.018
|
|
|
complement activation lectin pathway
|
GO:0001867 |
5 |
0.018
|
Human |
|
peptide secretion
|
GO:0002790 |
114 |
0.018
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.018
|
|
|
movement in environment of other organism involved in symbiotic interaction
|
GO:0052192 |
15 |
0.018
|
|
|
positive regulation of complement activation
|
GO:0045917 |
2 |
0.018
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.018
|
|
|
renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure
|
GO:0003072 |
5 |
0.018
|
Mouse |
|
tissue homeostasis
|
GO:0001894 |
115 |
0.018
|
|
|
fatty acid oxidation
|
GO:0019395 |
28 |
0.017
|
|
|
metencephalon development
|
GO:0022037 |
89 |
0.017
|
|
|
negative regulation of viral entry into host cell
|
GO:0046597 |
10 |
0.017
|
|
|
regulation of transmission of nerve impulse
|
GO:0051969 |
1 |
0.017
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.017
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
49 |
0.017
|
|
|
hindbrain morphogenesis
|
GO:0021575 |
46 |
0.017
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.017
|
|
|
limb development
|
GO:0060173 |
166 |
0.017
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.017
|
|
|
positive regulation of cytokine secretion
|
GO:0050715 |
41 |
0.017
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.017
|
|
|
response to purine containing compound
|
GO:0014074 |
28 |
0.017
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.017
|
|
|
mineralocorticoid biosynthetic process
|
GO:0006705 |
1 |
0.017
|
|
|
ear development
|
GO:0043583 |
200 |
0.017
|
|
|
reactive oxygen species biosynthetic process
|
GO:1903409 |
8 |
0.017
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.016
|
|
|
response to reactive oxygen species
|
GO:0000302 |
56 |
0.016
|
|
|
regulation of metanephric mesenchymal cell migration
|
GO:2000589 |
2 |
0.016
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.016
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.016
|
|
|
positive regulation of glucose import
|
GO:0046326 |
14 |
0.016
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.016
|
|
|
response to nutrient
|
GO:0007584 |
12 |
0.016
|
|
|
positive regulation of endocytosis
|
GO:0045807 |
42 |
0.016
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.016
|
|
|
regulation of lipid biosynthetic process
|
GO:0046890 |
54 |
0.016
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.016
|
|
|
b cell mediated immunity
|
GO:0019724 |
71 |
0.016
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.016
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
81 |
0.016
|
|
|
odontogenesis
|
GO:0042476 |
78 |
0.016
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.016
|
|
|
cellular response to interferon gamma
|
GO:0071346 |
25 |
0.016
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.016
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.016
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.016
|
|
|
immunoglobulin production
|
GO:0002377 |
73 |
0.015
|
|
|
regulation of phospholipid biosynthetic process
|
GO:0071071 |
3 |
0.015
|
|
|
establishment of tissue polarity
|
GO:0007164 |
28 |
0.015
|
|
|
lipid modification
|
GO:0030258 |
65 |
0.015
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.015
|
|
|
transition metal ion transport
|
GO:0000041 |
38 |
0.015
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.015
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.015
|
|
|
negative regulation of biomineral tissue development
|
GO:0070168 |
11 |
0.015
|
|
|
negative regulation of oxidative stress induced intrinsic apoptotic signaling pathway
|
GO:1902176 |
4 |
0.015
|
|
|
response to glucocorticoid
|
GO:0051384 |
20 |
0.015
|
|
|
regulation of striated muscle cell differentiation
|
GO:0051153 |
81 |
0.015
|
|
|
kidney morphogenesis
|
GO:0060993 |
83 |
0.015
|
|
|
cardiac muscle tissue development
|
GO:0048738 |
130 |
0.015
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
37 |
0.015
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.015
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.015
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.015
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.015
|
|
|
positive regulation of lipid metabolic process
|
GO:0045834 |
40 |
0.015
|
|
|
metanephric glomerular epithelial cell development
|
GO:0072313 |
2 |
0.015
|
|
|
regulation of carbohydrate biosynthetic process
|
GO:0043255 |
40 |
0.015
|
|
|
intrinsic apoptotic signaling pathway in response to oxidative stress
|
GO:0008631 |
19 |
0.015
|
|
|
positive regulation of defense response
|
GO:0031349 |
124 |
0.015
|
|
|
neuromuscular process
|
GO:0050905 |
99 |
0.015
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.015
|
|
|
iron ion homeostasis
|
GO:0055072 |
36 |
0.015
|
|
|
neutrophil chemotaxis
|
GO:0030593 |
36 |
0.015
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.014
|
|
|
import into cell
|
GO:0098657 |
8 |
0.014
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.014
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
40 |
0.014
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.014
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.014
|
|
|
regulation of fatty acid biosynthetic process
|
GO:0042304 |
12 |
0.014
|
|
|
lipid oxidation
|
GO:0034440 |
29 |
0.014
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.014
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.014
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.014
|
|
|
negative regulation of response to oxidative stress
|
GO:1902883 |
10 |
0.014
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.014
|
|
|
positive regulation of granulocyte chemotaxis
|
GO:0071624 |
12 |
0.014
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.014
|
|
|
platelet derived growth factor receptor alpha signaling pathway
|
GO:0035790 |
3 |
0.014
|
|
|
acute inflammatory response
|
GO:0002526 |
41 |
0.014
|
Human |
|
neural tube formation
|
GO:0001841 |
108 |
0.014
|
|
|
regulation of viral entry into host cell
|
GO:0046596 |
12 |
0.014
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.014
|
|
|
regionalization
|
GO:0003002 |
337 |
0.013
|
|
|
regulation of syncytium formation by plasma membrane fusion
|
GO:0060142 |
23 |
0.013
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.013
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.013
|
|
|
cardiac chamber morphogenesis
|
GO:0003206 |
93 |
0.013
|
|
|
positive regulation of camp dependent protein kinase activity
|
GO:2000481 |
3 |
0.013
|
|
|
cellular biogenic amine metabolic process
|
GO:0006576 |
28 |
0.013
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.013
|
|
|
astrocyte development
|
GO:0014002 |
12 |
0.013
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.013
|
|
|
metanephric glomerular epithelial cell differentiation
|
GO:0072312 |
2 |
0.013
|
|
|
positive regulation of epithelial cell differentiation involved in kidney development
|
GO:2000698 |
2 |
0.013
|
|
|
regulation of phospholipase a2 activity
|
GO:0032429 |
3 |
0.013
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.013
|
|
|
interleukin 12 secretion
|
GO:0072610 |
3 |
0.013
|
|